Essity weighs options for its consumer tissue business
06/05/2026 19:03
Repeats story to add company identifier, no other changes to text May 6 (Reuters) - Tissue maker Essity ESSITYa.ST is weighing options, including separation of its consumer tissue business, it said in a statement on Wednesday. The unit includes approximately 13,000 employees and 29 production facilities and generated sales of 43.5 billion Swedish krona ($4.71 billion) last year, the company said. ($1 = 9.2315 Swedish crowns) (Reporting by Kanjyik Ghosh in Barcelona; Editing by Emelia Sithole-Matarise) ((kanjyik.ghosh@thomsonreuters.com))
Recent news on Essity AB (publ)
See all newsEurope Research Roundup: Aixtron, Lenzing, Novo Nordisk
Brief: Finansinspektionen: Katarina Martinson Bought Around SEK 129 Million Worth Of Essity Shares
Corrected: BRIEF-Essity Board Member Buys SEK 29.6 Mln Worth Of Essity Shares
Brief: Essity Targets Adjusted EBITA Margin Above 12-19%
Brief: Essity Says Board To Evaluate Alternatives For Consumer Tissue, Including Potential Separation